Conference Exhibitors

Cipla has been developing respiratory medicines for patients for more than 40 years and we are the second largest global manufacturer of respiratory inhalers, committed to becoming a global leader in respiratory care. We have a range of high-quality respiratory products, designed with similar instructions and features to the market-leading originator brands. At Cipla, we have priced our range to be more sustainable and affordable so more NHS patients can receive optimal care. We are dedicated to minimising our environmental footprint in support of the NHS goal of becoming carbon net zero by 2040.
CIPCOR20240038 October 2024

Inspiring confidence, empowering clinical excellence.

Clement Clarke International is a UK manufacturer, providing the gold standard Mini-Wright peak flow meters, inhalation spacers, nebulisers and mucus clearance devices that cover diagnosis, monitoring and treatment of many respiratory conditions such as Asthma and COPD, to suit the needs and requirements of patients and improve inhaler technique.

Clement Clarke International was acquired by Flexicare, a leading designer and global provider of medical devices. With over 35 years of experience, Flexicare has supported clinicians worldwide to enhance patient outcomes with class leading devices.

Glenmark is a research‐led, global pharmaceutical company, with presence across branded, generics, and OTC segments; our focus therapy areas are Respiratory, Dermatology and Oncology. We are focused on developing bioequivalent as well as innovative medicines that make a difference to the NHS and fulfil the unmet needs of patients. July 2025, PP-UK-Bun-0125

GSK are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in new commitments to growth and a step-change in performance.
NP-GB-RS-COCO-230002 | January 2024

Intermedical is a specialist provider of cardio-respiratory diagnostic equipment. We are the exclusive UK partner for Bedfont Scientific, offering the NObreath® FeNO device and the Smokerlyzer® range. Additionally, we are the UK distributor for Ndd lung function systems and MIR spirometers.

At Kenvue, we realize the extraordinary power of everyday care. Through our iconic brands – including Aveeno®, Johnson’s®, Listerine®, Neutrogena® and Nicorette® – we put this power into the hands of approximately 1.2 billion people globally, in their daily rituals and the moments that matter most. We are 22,000 dynamic and diverse team members, passionate about insights, innovation and making an impact. We are united by an unwavering courage to see and solve everyday care needs by delivering science-backed, care-forward experiences that are endorsed by healthcare professionals. With expertise and empathy, we believe in meaningful possibilities for healthier people and a healthier planet. And we’re focused on their pursuit. As the world’s largest pure-play consumer health company by revenue, we bring a new view of everyday care to the world. Learn more at https://kenvuepro.com/en-gb/

Lupin Healthcare delivers affordable, sustainable, high-quality medicines where they’re needed most - supporting the UK healthcare system.
We specialise in building brands with complex molecules and applying innovative thinking. Entrepreneurial and collaborative, combining global strength with local autonomy to tackle unmet needs.
Lupin Healthcare: sustainable solutions for a healthier future.

NSHI are an independent leading health services provider who delivers improved patient outcomes in primary, secondary and remote healthcare.

Our specialist clinical services use innovative technology to support healthcare communities to drive quality improvements, and implement NHS Strategies effectively and efficiently.

NIOX Group plc is the global leader in FeNO testing, with a strong reputation for innovation and excellence in the development of medical devices for the diagnosis and management of asthma. With NIOX VERO®, healthcare professionals have a reliable and non-invasive tool to help them better diagnose and manage asthma.

SPIROCONNECT SPIROMETER
SpiroConnect is the most accurate, comprehensive, and simple to use spirometry solution available. It is fully integrated with EMIS, SystmOne and Vision making it safer, faster and easier to use, and compliant with the latest spirometry standards.

SpiroConnect can be purchased outright or rented from just £41 + VAT per month, including installation, product training, clinical system integration and Numed's comprehensive MediServe support package.

WHAT DO OUR CUSTOMERS THINK?
“As a Respiratory Nurse Specialist with over 16 years’ experience delivering spirometry training in the Primary Care sector, I have used all makes and models of spirometer. I was introduced to the SpiroConnect system approximately 10 years ago. The design, accuracy and ease of use of SpiroConnect, in addition to after sales support and commitment to product development is the best I’ve ever experienced. I now recommend SpiroConnect to any practice/hub looking to upgrade their spirometry equipment” – Sophie Toor – Primary Care Respiratory Nurse Specialist and Clinical Director of Respiratory Matters, a leading spirometry training provider.

FeNO AND CO BREATH TESTING
Our respiratory range also includes FeNO and Carbon Monoxide breath testing equipment.

For more information, visit the Numed Healthcare stand at the PCRS exhibition or contact us:

Website: www.numed.co.uk
Email: info@numed.co.uk
Telephone: 0114 2433896

Orion Pharma (UK) Ltd. is a wholly owned subsidiary of Orion Corporation, a pharmaceutical company based in Finland. Our principal role is to represent Orion's pharmaceutical products in the UK across a range of therapy areas including Respiratory, Women’s Health and Neurological Disorders.
In the spirit of the values which are common to all units and employees of the Group, we endeavour to provide innovative medicinal treatments and best quality service to patients, healthcare professionals and the community in the UK, the region we operationally cover.
We are continuously developing new drugs and treatment methods. The core therapy areas of our pharmaceutical R&D are oncology and pain. We collaborate closely with healthcare professionals and leading global research institutions and pharmaceutical companies.
www.orionpharma.co.uk

July 2025/CORP-233(4)

Pulmonx is based in Redwood City, California, and Neuchâtel, Switzerland. The company’s commercially available portfolio includes the Zephyr® Valve. More than 100 scientific articles have been published on the clinical benefits of Zephyr Valves, including multiple meta-analyses, review articles, cost-effectiveness analyses and risk-benefit analyses. It also includes:

The Zephyr Valve:
The Zephyr Endobronchial Valve is an implantable device used to occlude all airways feeding the hyperinflated lobe of a lung that is most diseased with emphysema.

StratX® Lung Analysis Reports
A cloud-based quantitative computed tomography (CT) analysis service that provides information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the Zephyr Valve treatment.

The Chartis® Pulmonary Assessment System
A proprietary balloon catheter and console provides precise flow and pressure readings for specific lobes in the lung to assess absence of collateral ventilation.

This combination of assessment tools and therapeutics enables physicians to successfully predict outcomes and provide optimal treatment for each individual patient.

For over two decades, Rotherham Respiratory has been a leader in respiratory and long-term conditions education. We empower healthcare professionals to deliver exceptional, patient-centered care through evidence-based programs led by experienced clinicians. Our practical, clinically-relevant courses provide the knowledge and confidence needed to make a positive impact on patient outcomes.

Thornton & Ross, part of the STADA group, focuses on caring for people’s health through a broad portfolio including generics, biosimilars and non-prescription consumer healthcare products as a trusted partner supplying the NHS. STADA sells its products in more than 120 countries, employing over 12,000 people worldwide.

Thermo Fisher Scientific is a global leader in allergy and autoimmunity diagnostics, providing you with accurate and clinically relevant testing solutions to aid in disease diagnosis and patient management.

TidalSense is an innovative respiratory diagnostics company based in Cambridge, UK. We are now launching N-Tidal™ Diagnose - a regulated, secure class 2a medical device diagnostic solution delivered as a service. It combines state of the art hardware (N-Tidal™) with AI-powered diagnostic software to deliver COPD diagnosis at the point of care within minutes.

Leveraging a revolutionary new patented sensor technology, N-Tidal™ Diagnose performs real-time geometric analysis of CO2 breath waveforms to provide highly sensitive quantification of lung function, from relaxed breathing.

TriOn Pharma is a dynamic UK-based Nutraceutical, Pharmaceutical, and Medical Device company, committed to pioneering innovative, high-quality, and cost-effective products to enhance health and well-being. As an ethical pharmaceutical firm, we collaborate with the NHS to optimize drug budgets without compromising quality.

Our mission is to improve patients lives by designing and manufacturing marketing leading products and services. Our intention is to have a real impact in the effective management of respiratory diseases. We provide a wide variety of precise, intuitive devices for respiratory care including spirometers, lung & asthma monitors, COPD screeners, FeNO, and medical workstations as well as software and consumables.

Our friendly and knowledge experts will be available throughout the conference to chat about your needs.

Visit our website www.vitalograph.com or call us on 01280 827110.

Welcome to Wockhardt, a UK pharmaceutical manufacturer based in Wrexham (North Wales) with an established heritage and evolving role in medicines supply. From biotechnology start-ups to high-volume commercial manufacture, we utilise more than six decades of manufacturing experience. Wockhardt also supply a large portfolio of quality generic products covering most major therapeutic areas, providing access to affordable medicines both in the UK and across the world.
Wockhardt UK is part of Wockhardt Ltd, a research based global pharmaceutical and biotech company.
With a key focus on new antibiotic drug discovery to combat antibiotic resistance and biosimilars to tackle unmet needs in diabetes care, we’re accelerating the development of life-saving drugs benefiting patients worldwide.

We will provide more info upon meeting approval by our medical department if that's ok